Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+10.89%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$469M
Cap. Flow %
-3.16%
Top 10 Hldgs %
34.28%
Holding
1,313
New
28
Increased
616
Reduced
266
Closed
37

Sector Composition

1 Real Estate 59.2%
2 Technology 7.88%
3 Communication Services 4.42%
4 Consumer Discretionary 3.52%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PLRX icon
1126
Pliant Therapeutics
PLRX
$114M
$2K ﹤0.01%
67
PSNL icon
1127
Personalis
PSNL
$465M
$2K ﹤0.01%
73
RIGL icon
1128
Rigel Pharmaceuticals
RIGL
$742M
$2K ﹤0.01%
37
RNA icon
1129
Avidity Biosciences
RNA
$6.48B
$2K ﹤0.01%
71
RPTX icon
1130
Repare Therapeutics
RPTX
$72.6M
$2K ﹤0.01%
69
RYTM icon
1131
Rhythm Pharmaceuticals
RYTM
$6.78B
$2K ﹤0.01%
98
SNDX icon
1132
Syndax Pharmaceuticals
SNDX
$1.47B
$2K ﹤0.01%
93
SRRK icon
1133
Scholar Rock
SRRK
$3.02B
$2K ﹤0.01%
63
STOK icon
1134
Stoke Therapeutics
STOK
$1.13B
$2K ﹤0.01%
68
STRO icon
1135
Sutro Biopharma
STRO
$89.9M
$2K ﹤0.01%
89
CCXI
1136
DELISTED
ChemoCentryx, Inc.
CCXI
$2K ﹤0.01%
137
FMTX
1137
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$2K ﹤0.01%
89
ENDP
1138
DELISTED
Endo International plc
ENDP
$2K ﹤0.01%
433
RDUS
1139
DELISTED
Radius Health, Inc.
RDUS
$2K ﹤0.01%
88
EPZM
1140
DELISTED
Epizyme, Inc
EPZM
$2K ﹤0.01%
191
ZGNX
1141
DELISTED
Zogenix, Inc.
ZGNX
$2K ﹤0.01%
105
AFMD
1142
DELISTED
Affimed
AFMD
$2K ﹤0.01%
19
AKRO icon
1143
Akero Therapeutics
AKRO
$3.58B
$2K ﹤0.01%
65
ATRA icon
1144
Atara Biotherapeutics
ATRA
$90.7M
$2K ﹤0.01%
6
AERI
1145
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$2K ﹤0.01%
102
ADVM icon
1146
Adverum Biotechnologies
ADVM
$73.9M
$1K ﹤0.01%
18
AKBA icon
1147
Akebia Therapeutics
AKBA
$785M
$1K ﹤0.01%
316
INZY
1148
DELISTED
Inozyme Pharma
INZY
$1K ﹤0.01%
44
KALA icon
1149
KALA BIO
KALA
$102M
$1K ﹤0.01%
2
KALV icon
1150
KalVista Pharmaceuticals
KALV
$796M
$1K ﹤0.01%
46